Previous 10 | Next 10 |
Novavax's Updated COVID-19 Vaccine Now Authorized in Canada Canada NewsWire Novavax's updated protein-based non-mRNA COVID-19 vaccine will be available in Canada for individuals aged 12 and older in the coming days GAITHERSBURG, Md. , Dec. 5, 2023 ...
2023-11-28 06:20:57 ET Novavax ( NASDAQ: NVAX ) shares gained 4% premarket on Tuesday after the vaccine maker was granted emergency use listing by the World Health Organization for its updated protein-based COVID-19 vaccine, Nuvaxovid XBB.1.5 Covid-19 Vaccine (NVX-CoV2601). ...
Novavax's Updated Protein-based COVID-19 Vaccine Now an Option for All 194 Member States of the World Health Organization PR Newswire GAITHERSBURG, Md. , Nov. 28, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vac...
2023-11-24 12:35:42 ET More on BioNTech, GSK, etc. BioNTech Vs. Moderna: Navigating The mRNA Landscape Pfizer Is A Fantastic Buy And So Are These 9%-Yielding Blue Chips Moderna Nears Key Technical Level With Indications Of Reversal (Rating Upgrade) GSK makes ...
2023-11-17 11:46:02 ET Summary Moderna, Inc. reported weak Covid vaccine sales and cut revenue targets for 2023 and 2024. Covid vaccine demand is lower than predicted, with Moderna now guiding to only 50 million doses this year while demand might dip to only 30 million. The st...
2023-11-17 08:01:25 ET Novavax ( NASDAQ: NVAX ) on Friday announced changes to its leadership team and named John Trizzino to the new role of president and chief operating officer. In the newly created role, Trizzino will lead commercial; chemistry, manufacturing and contr...
2023-11-17 05:55:00 ET Summary Biotech sector faces challenges including higher interest rates, inflation, regulatory pressures, and a post-COVID slump. Short interest remains high for some pharmaceutical companies, indicating bearish sentiment. Exchange-traded funds in the bi...
2023-11-15 15:54:50 ET Billionaire investor Philippe Laffont's Coatue Management cut most of its stakes in members of the "Magnificent 7" club in Q3 2023, while taking new positions in data analytics software company Palantir Technologies ( NYSE: PLTR ) and Canadian e-commerce ...
2023-11-15 06:12:08 ET Novavax, Inc. (NVAX) Jefferies London Healthcare Conference November 15, 2023, 04:00 AM ET Company Participants Roger Song - Jefferies Conference Call Participants John Jacob - President & CEO Filip Dubovsky - President of Resea...
2023-11-15 05:20:00 ET Wall Street traders have numerous (and often creative) strategies to speculate on stocks and their up and down price movements. There are times when the prices of stocks are influenced more by what these traders do rather than by the company's business operations. One...
News, Short Squeeze, Breakout and More Instantly...
2024-06-26 10:47:03 ET Novavax, Inc. (NVAX) NVAX is trading DOWN for the last 4 days, and it at trading at $13.72 with volume of 2,036,792 and a one day change of $-0.28 (-2.00%). Novavax, Inc. has a 52-week low of 3.53 and a 52-week high of $23.86. The business's 50-day moving aver...
Novavax Submits Application to European Medicines Agency for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine PR Newswire Novavax's JN.1 COVID-19 vaccine is active against current circulating strains, including KP.2 and KP.3 GAITHERSBURG, Md. , Ju...